Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Tegoprazan vs Placebo for Prevention of Gastrointestinal Complications in Ischemic Stroke Patients on Antiplatelet Therapy
KCT0011041Phase 3Not yet recruiting
- Sponsor
- HK inno.N Corporation
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegoprazan in ischemic stroke, sponsored by HK inno.N Corporation. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
tegoprazan
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on KCT0011041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011041.